Memorial Şişli Hospital
Bookimedは臍帯血幹細胞療法価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックで臍帯血幹細胞療法代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。臍帯血幹細胞療法で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。臍帯血幹細胞療法の旅路でお一人になることはありません。
Dr. Husrev Diktas is an Associate Professor of Infectious Diseases at Medipol Acibadem District Hospital. He specializes in vaccine immunology and molecular biology. Dr. Diktas served as an Associate Research Scientist at the Yale School of Medicine. He conducted research there to improve vaccines against tick-borne diseases like Lyme and Babesiosis.
Dr. Nail Paksoy is an associate professor of medical oncology at Medipol Bahçelievler Hospital. He is board-certified by the European Society for Medical Oncology (ESMO). Dr. Paksoy specializes in lung, breast, and gastrointestinal cancers. He uses modern immunotherapy and targeted therapy protocols. His clinic is JCI-accredited for high safety standards.
Dr. Sevil Bilir is an associate professor and pediatrician at Medipol Acibadem District Hospital in Istanbul. She holds a PhD in pediatrics from Istanbul Haydarpaşa Numune Training and Research Hospital. Dr. Bilir has worked extensively in both public university hospitals and private medical centers. She treats children and teens for a variety of general and specialized health conditions.
幹細胞研究において40年の経験以上の経験を持つカラオズ博士は、コジャエリ大学にトルコ初の機関幹細胞研究開発センターを設立し、先駆的な役割を果たしました。同博士の研究は、脳性麻痺や多発性硬化症などの疾患に対する治療法の発展に貢献しています。
Umbilical cord stem cell therapy in Turkey is generally safe at JCI-accredited clinics using Good Manufacturing Practice (GMP) laboratories. Common side effects include temporary fever, injection site redness, or fatigue. While rare, serious risks include blood clots, infection from contaminated cultures, or immune reactions to cell media.
Bookimed Expert Insight: High-quality Turkish centres use closed-system cell processing rather than manual handling. Prof. Erdal Karaöz at Liv Hospital managed ministry-approved clinical trials using these strict protocols. Patients should prioritise clinics with on-site GMP laboratories. This significantly reduces the risk of cell contamination during transport or cryobanking.
Patient Consensus: Patients in Turkey often report short-term anxiety or irritability similar to high-dose steroids. Most emphasise that verifying laboratory sterility and GMP compliance is vital. These factors are more important than hotel-style amenities or package inclusions.
Verifying clinic quality for stem cell therapy in Turkey involves confirming Joint Commission International (JCI) accreditation. You should also check for Good Manufacturing Practice (GMP) laboratory standards. Reliable centres like Liv Hospital Ulus and Memorial Şişli Hospital use closed-system processing. They also use Ministry-approved clinical trial protocols for cell viability and patient safety.
Bookimed Expert Insight: Data shows Turkey’s leading stem cell centres maintain internal GMP labs (LivMedCell). Choosing a clinic with on-site production ensures higher cell freshness and stricter sterility. Istanbul centres now serve patients from over 167 countries.
Patient Consensus: Patients in Turkey recommend requesting written cell dose and processing data. They suggest prioritising doctor-led clinics over marketing-focused centres. Success often depends on clear follow-up plans. Patients should also verify the exact cell source, like umbilical cord matrix, before arrival.
Turkish specialists use umbilical cord mesenchymal stem cells to treat chronic neurological, autoimmune, and musculoskeletal conditions. Common applications include cerebral palsy, multiple sclerosis, spinal cord injuries, and osteoarthritis. Accredited facilities like Liv Hospital Ulus use GMP-standard labs for precise cell isolation and sterile processing.
Bookimed Expert Insight: Success in Turkey often links to what happens after the injection. Specialists like Dr. Asena Paran or Dr. Erdal Karaöz emphasise neuroplasticity-focused rehabilitation after therapy. This structured post-treatment support helps patients translate biological cellular changes into functional improvements. These include better walking or reduced spasticity.
Patient Consensus: Patients in Turkey typically focus on symptom relief for multiple sclerosis. They also seek help for spinal cord injuries and chronic nerve pain. Most report incremental gains in bladder control and sensation rather than total cures.
Turkey is a leading centre for umbilical cord stem cell therapy. It has strong Good Manufacturing Practice (GMP) laboratories and JCI-accredited hospitals. Specialists use allogeneic mesenchymal stem cells from umbilical cord matrix. These treat complex neurological, orthopaedic, and autoimmune conditions.
Bookimed Expert Insight: Bookimed data shows Turkey provides fast access to regenerative medicine compared to Australia. While Australian patients often face long waits for trials, Turkish centres have virtually no waiting lists. Medipol Mega University Hospital serves 1,000,000+ patients annually. This high-volume environment allows clinicians to refine protocols across thousands of cases.
Patient Consensus: Patients value the combination of cost-effective care and professional medical-tourism support in Turkey. Many describe a friendly atmosphere. They find that integrated travel and interpretation services make navigating complex treatments much easier.
Umbilical cord stem cells in Turkey are collected from donors after healthy deliveries using sterile, non-invasive methods. Processing occurs in specialised Good Manufacturing Practice (GMP) laboratories. Technicians isolate and expand mesenchymal stem cells (MSCs) from the cord matrix before cryopreservation or clinical use.
Bookimed Expert Insight: Turkish facilities like Liv Hospital Ulus often have internal GMP-standard production centres on-site. This allows professors like Dr Erdal Karaöz to oversee the entire chain from isolation to infusion. These integrated hospital labs provide higher cell viability than clinics that outsource their manufacturing.
Patient Consensus: Patients value transparency regarding donor screening and laboratory standards in Turkey. Many recommend asking for written proof of cell viability and passage numbers. This confirms the treatment is fresh and potent.
An umbilical cord stem cell treatment trip to Turkey typically lasts 5 to 10 days. Simple cases may require only 3 nights. Complex neurological or orthopaedic conditions often involve a 14-day stay. This extended window allows for rehabilitation and physical therapy alongside the cell administration.
Bookimed Expert Insight: Turkish specialists often differentiate between the travel window and the therapeutic window. While the procedure finishes in days, clinics like Rumi Pulse focus on the 3 to 6 month window for results. Choosing a centre with established Good Manufacturing Practice labs helps ensure cells are processed locally. This often reduces the wait time for administration.
Patient Consensus: The trip is usually a short medical visit focused on the procedure with brief in-country monitoring. People suggest planning for gradual improvements over 12 months rather than expecting immediate results during the stay in Turkey.